ARANX
Price
$25.78
Change
+$0.05 (+0.19%)
Updated
Jul 25 closing price
Net Assets
1.39B
SRGCX
Price
$13.03
Change
+$0.02 (+0.15%)
Updated
Jul 25 closing price
Net Assets
23.17M
Interact to see
Advertisement

ARANX vs SRGCX

Header iconARANX vs SRGCX Comparison
Open Charts ARANX vs SRGCXBanner chart's image
Horizon Active Risk Assist® Investor
Price$25.78
Change+$0.05 (+0.19%)
VolumeN/A
Net Assets1.39B
Stringer Tactical Adaptive Risk C
Price$13.03
Change+$0.02 (+0.15%)
VolumeN/A
Net Assets23.17M
ARANX vs SRGCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ARANX vs. SRGCX commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARANX is a Buy and SRGCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ARANX has more cash in the bank: 1.4B vs. SRGCX (23.2M). ARANX (0.51) and SRGCX (0.50) have matching dividends . ARANX was incepted earlier than SRGCX: ARANX (11 years) vs SRGCX (12 years). SRGCX (3.31) is less costly to investors than ARANX (1.28). SRGCX is a more actively managed with annual turnover of: 133.00 vs. ARANX (66.00). ARANX has a lower initial minimum investment than SRGCX: ARANX (2500) vs SRGCX (5000). SRGCX annual gain was more profitable for investors over the last year : 7.54 vs. ARANX (1.36). ARANX return over 5 years is better than : 37.95 vs. SRGCX (10.88).
ARANXSRGCXARANX / SRGCX
Total Expense Ratio1.282.3155%
Annual Report Gross Expense Ratio1.283.3139%
Fund Existence11 years12 years-
Gain YTD7.3276.541112%
Front LoadN/AN/A-
Min. Initial Investment2500500050%
Min. Initial Investment IRAN/AN/A-
Net Assets1.4B23.2M6,013%
Annual Yield % from dividends0.510.50102%
Returns for 1 year1.367.5418%
Returns for 3 years25.0622.86110%
Returns for 5 years37.9510.88349%
Returns for 10 years34.4813.78250%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LXEO4.130.46
+12.53%
Lexeo Therapeutics
TGT106.050.23
+0.22%
Target Corp
CYTK37.18-0.13
-0.35%
Cytokinetics
CRON2.05-0.02
-0.97%
Cronos Group
MOB3.54-0.14
-3.80%
Mobilicom Limited